Nagano, Y., Yokouchi, H., Saito, R., Honjo, O., Sumi, T., Kaburagi, T., Ito, K., Ikezawa, Y., Yokoo, K., Kikuchi, H., Shigaki, R., Tagami, K., Tenma, T., Ishikawa, T., Takahashi, M., Sasaki, T., Asahina, H., Hinotsu, S., Chiba, H., Oizumi, S. (2026). Afatinib versus osimertinib for non–small cell lung cancer with uncommon epidermal growth factor receptor mutations: Real-world outcomes (HOT-Next001/HOT2501).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.8605